{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T13:04:36Z","timestamp":1772111076694,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,26]]},"DOI":"10.7759\/cureus.104282","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:15:46Z","timestamp":1772108146000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes and Real-World Effectiveness of Amoxicillin-Clavulanic Acid Across Indian Healthcare Settings: A Retrospective Multicenter Study"],"prefix":"10.7759","author":[{"given":"Anand","family":"Raju","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D K","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sambit Kumar","family":"Behera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Pal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/2042098614554919","article-title":"Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem","volume":"5","author":"Llor C","year":"2014","unstructured":"Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014, 5:229-41. 10.1177\/2042098614554919","journal-title":"Ther Adv Drug Saf"},{"key":"ref2","unstructured":"Antimicrobial stewardship programmes in healthcare facilities. a WHO practical toolkit. (2019). Accessed: January 10, 2026: https:\/\/iris.who.int\/items\/c67b8194-1689-4b1c-9e3a-d49c4b950fd6."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00037-09","article-title":"Three decades of beta-lactamase inhibitors","volume":"23","author":"Drawz SM","year":"2010","unstructured":"Drawz SM, Bonomo RA. Three decades of beta-lactamase inhibitors. Clin Microbiol Rev. 2010, 23:160-201. 10.1128\/CMR.00037-09","journal-title":"Clin Microbiol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh050","article-title":"Augmentin (amoxicillin\/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent","volume":"53 Suppl 1","author":"White AR","year":"2004","unstructured":"White AR, Kaye C, Poupard J, Pypstra R, Woodnutt G, Wynne B. Augmentin (amoxicillin\/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent. J Antimicrob Chemother. 2004, 53 Suppl 1:i3-20. 10.1093\/jac\/dkh050","journal-title":"J Antimicrob Chemother"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-020-00374-7","article-title":"Orally administered amoxicillin\/clavulanate: current role in outpatient therapy","volume":"10","author":"Veeraraghavan B","year":"2021","unstructured":"Veeraraghavan B, Bakthavatchalam YD, Sahni RD. Orally administered amoxicillin\/clavulanate: current role in outpatient therapy. Infect Dis Ther. 2021, 10:15-25. 10.1007\/s40121-020-00374-7","journal-title":"Infect Dis Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.23736\/S0026-4806.25.09808-8","article-title":"Amoxicillin\/clavulanate as a cornerstone of antibiotic stewardship: integrating WHO AWaRe principles, Italian recommendations, and evidence-based practice","volume":"116","author":"Mattina R","year":"2025","unstructured":"Mattina R, Scaglione F. Amoxicillin\/clavulanate as a cornerstone of antibiotic stewardship: integrating WHO AWaRe principles, Italian recommendations, and evidence-based practice. Minerva Med. 2025, 116:497-503. 10.23736\/S0026-4806.25.09808-8","journal-title":"Minerva Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmmb.2025.100829","article-title":"An evaluation of antibiotic prescription pattern and drug rationality analysis among outpatients at public health setting, India","volume":"55","author":"Modgil V","year":"2025","unstructured":"Modgil V, Shafiq N, Gondara A, et al.. An evaluation of antibiotic prescription pattern and drug rationality analysis among outpatients at public health setting, India. Indian J Med Microbiol. 2025, 55:100829. 10.1016\/j.ijmmb.2025.100829","journal-title":"Indian J Med Microbiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18535\/ijmsci\/v11i7.06","article-title":"Expert perspectives on the prescription pattern of co-amoxiclav in the management of infections in Indian settings","volume":"11","author":"Manjula S","year":"2024","unstructured":"Manjula S, Krishna Kumar M. Expert perspectives on the prescription pattern of co-amoxiclav in the management of infections in Indian settings. IJMSCI. 2024, 11:7217-7222. 10.18535\/ijmsci\/v11i7.06","journal-title":"IJMSCI"},{"key":"ref9","article-title":"Effect of the administration of a probiotic with a combination of Lactobacillus and Bifidobacterium strains on antibiotic-associated diarrhea","volume":"32","author":"Garc\u00eda Trallero O","year":"2019","unstructured":"Garc\u00eda Trallero O, Herrera Serrano L, Bibi\u00e1n Ingl\u00e9s M, Roche Vall\u00e9s D, Rodr\u00edguez AM. Effect of the administration of a probiotic with a combination of Lactobacillus and Bifidobacterium strains on antibiotic-associated diarrhea. Rev Esp Quimioter. 2019, 32:268-72.","journal-title":"Rev Esp Quimioter"},{"key":"ref10","unstructured":"Respiratory tract infections (self-limiting). prescribing antibiotics. (2019). Accessed: January 10, 2026: https:\/\/www.nice.org.uk\/guidance\/cg69."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l440","article-title":"Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines","volume":"364","author":"Pouwels KB","year":"2019","unstructured":"Pouwels KB, Hopkins S, Llewelyn MJ, Walker AS, McNulty CA, Robotham JV. Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. BMJ. 2019, 364:l440. 10.1136\/bmj.l440","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-025-10967-7","article-title":"A retrospective clinical evaluation of the quality of antibiotic use in treating ear, nose and throat infections in ambulatory care setting of a teaching hospital in Ghana: findings and implications","volume":"25","author":"Sefah IA","year":"2025","unstructured":"Sefah IA, Dzonu IR, Korbuvi J, et al.. A retrospective clinical evaluation of the quality of antibiotic use in treating ear, nose and throat infections in ambulatory care setting of a teaching hospital in Ghana: findings and implications. BMC Infect Dis. 2025, 25:557. 10.1186\/s12879-025-10967-7","journal-title":"BMC Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000038630","article-title":"Antimicrobial management of dental infections: updated review","volume":"103","author":"Abdullah FM","year":"2024","unstructured":"Abdullah FM, Hatim QY, Oraibi AI, Alsafar TH, Alsandook TA, Lutfi W, Al-Hussaniy HA. Antimicrobial management of dental infections: updated review. Medicine (Baltimore). 2024, 103:e38630. 10.1097\/MD.0000000000038630","journal-title":"Medicine (Baltimore)"},{"key":"ref14","article-title":"Effectiveness and safety of co-amoxiclav in dental infections: a multicenter, real-world study","volume":"4","author":"Kumar T","year":"2025","unstructured":"Kumar T, Prakash J, Ahire JS, Pal A, Pawar D, Sharma A. Effectiveness and safety of co-amoxiclav in dental infections: a multicenter, real-world study. AMMS. 2025, 4:670-7.","journal-title":"AMMS"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/njms.njms_1_24","article-title":"Systemic complications of use of antibiotics following removal of the third molar: a systematic review","volume":"16","author":"Gulhane SV","year":"2025","unstructured":"Gulhane SV, Naphade MV, Gondhalekar R, Kolhe V, Pande P, Sakhare PV. Systemic complications of use of antibiotics following removal of the third molar: a systematic review. Natl J Maxillofac Surg. 2025, 16:233-41. 10.4103\/njms.njms_1_24","journal-title":"Natl J Maxillofac Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/M19-1509","article-title":"Duration of antibiotic therapy: shorter is better","volume":"171","author":"Spellberg B","year":"2019","unstructured":"Spellberg B, Rice LB. Duration of antibiotic therapy: shorter is better. Ann Intern Med. 2019, 171:210-1. 10.7326\/M19-1509","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1955-2","article-title":"Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI choosing wisely campaign","volume":"14","author":"Furlan L","year":"2019","unstructured":"Furlan L, Erba L, Trombetta L, et al.. Short- vs long-course antibiotic therapy for pneumonia: a comparison of systematic reviews and guidelines for the SIMI choosing wisely campaign. Intern Emerg Med. 2019, 14:377-94. 10.1007\/s11739-018-1955-2","journal-title":"Intern Emerg Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.08.004","article-title":"Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study","volume":"29","author":"Israelsen SB","year":"2023","unstructured":"Israelsen SB, Fally M, Tarp B, Kolte L, Ravn P, Benfield T. Short-course antibiotic therapy for hospitalized patients with early clinical response in community-acquired pneumonia: a multicentre cohort study. Clin Microbiol Infect. 2023, 29:54-60. 10.1016\/j.cmi.2022.08.004","journal-title":"Clin Microbiol Infect"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG clinical guideline: treatment of Helicobacter pylori infection","volume":"119","author":"Chey WD","year":"2024","unstructured":"Chey WD, Howden CW, Moss SF, Morgan DR, Greer KB, Grover S, Shah SC. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2024, 119:1730-53. 10.14309\/ajg.0000000000002968","journal-title":"Am J Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1046\/j.0954-6820.2003.01239.x","article-title":"Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate","volume":"255","author":"Ojetti V","year":"2004","unstructured":"Ojetti V, Migneco A, Zocco MA, Nista EC, Gasbarrini G, Gasbarrini A. Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. J Intern Med. 2004, 255:125-9. 10.1046\/j.0954-6820.2003.01239.x","journal-title":"J Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v6.i4.183","article-title":"Antibiotic treatment for Helicobacter pylori: is the end coming?","volume":"6","author":"Kim SY","year":"2015","unstructured":"Kim SY, Choi DJ, Chung JW. Antibiotic treatment for Helicobacter pylori: is the end coming?. World J Gastrointest Pharmacol Ther. 2015, 6:183-98. 10.4292\/wjgpt.v6.i4.183","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.11.059","article-title":"AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review","volume":"160","author":"Shah SC","year":"2021","unstructured":"Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review. Gastroenterology. 2021, 160:1831-41. 10.1053\/j.gastro.2020.11.059","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/158520","article-title":"Levofloxacin-amoxicillin\/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection","volume":"2014","author":"Chen MC","year":"2014","unstructured":"Chen MC, Lei WY, Lin JS, Yi CH, Wu DC, Hu CT. Levofloxacin-amoxicillin\/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection. Biomed Res Int. 2014, 2014:158520. 10.1155\/2014\/158520","journal-title":"Biomed Res Int"},{"key":"ref24","article-title":"ACG guideline: treatment of Helicobacter pylori infection: new recmmendations...will practice change?","volume":"166","author":"Schoenfeld PS","year":"2024","unstructured":"Schoenfeld PS. ACG guideline: treatment of Helicobacter pylori infection: new recmmendations...will practice change?. Gastroenterology. 2024, 166:612-638.","journal-title":"Gastroenterology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/455156-clinical-outcomes-and-real-world-effectiveness-of-amoxicillin-clavulanic-acid-across-indian-healthcare-settings-a-retrospective-multicenter-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:15:48Z","timestamp":1772108148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/455156-clinical-outcomes-and-real-world-effectiveness-of-amoxicillin-clavulanic-acid-across-indian-healthcare-settings-a-retrospective-multicenter-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.104282","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,26]]}}}